单细胞多组学在特发性肺纤维化与慢阻肺中的应用:从图谱到影响
本文综述单细胞与空间多组学技术在特发性肺纤维化(IPF)和慢性阻塞性肺疾病(COPD)研究中的进展。文章讨论了技术分析挑战、全球肺参考图谱及两病主要发现,并指出早期疾病阶段代表性不足等未来方向。
要点
- IPF机制涉及肺泡微环境丧失、基底样上皮细胞异常及促纤维化巨噬细胞和成纤维细胞亚型扩增。
- COPD中可见气细胞丢失、MMP表达巨噬细胞扩增、中性粒细胞流入及B细胞淋巴滤泡活化。
- 单细胞多组学与临床表型及影像整合有望推动精准医学、生物标志物发现和分层试验设计。
核心结论
- 单细胞与空间多组学技术正在改变对正常肺细胞组成及IPF和COPD分子细胞网络的理解。
- 与临床表型和影像整合可加速向精准医学转化,支持生物标志物发现、细胞内分型和治疗优先级排序。
研究设计与样本
- 本文为综述,聚焦特发性肺纤维化(IPF)和慢性阻塞性肺疾病(COPD)。
- 简要回顾相关技术并讨论技术与分析挑战,包括批次校正、数据集整合和样本感知的差异基因表达优化策略。
主要发现
- IPF中机制见解包括:正常肺泡微环境丧失、与再生失败相关的异常基底样上皮细胞、促纤维化SPP1+巨噬细胞扩增、疾病相关CTHRC1+和HAS1hi成纤维细胞亚型定位于纤维化微环境,以及广泛的血管和免疫重塑。
- COPD中这些方法显示:气细胞丢失、表达MMP的巨噬细胞扩增、活化中性粒细胞流入、B细胞淋巴滤泡活化和内皮炎症,以及与IPF某些重叠特征。
临床怎么用
- 利用全球肺参考图谱进行跨研究验证、谱系和轨迹推断及疾病间比较。
- 将单细胞多组学与临床表型和影像整合,以促进生物标志物发现、细胞内分型和治疗优先级排序。
局限性
- 早期疾病阶段代表性不足。
- 中性粒细胞、组织驻留免疫区室解析不完整。
- 缺乏跨器官整合。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Single-cell and spatial multi-omics technologies are transforming our understanding of the normal lung cellular repertoire as well the molecular and cellular networks of chronic lung diseases. In this review we focus on idiopathic pulmonary fibrosis (IPF) and chronic obstructive pulmonary disease (COPD). We briefly review technologies and discuss technical and analytical challenges, including strategies to optimise batch correction, dataset integration, and sample-aware differential gene expression; we describe global lung reference atlases, enabled by large-scale data-sharing, providing accessible frameworks for cross-study validation, lineage and trajectory inference, and inter-disease comparisons; and we outline the major findings in COPD and IPF. In IPF, mechanistic insights include: (i) loss of the normal alveolar niche (ii) aberrant basaloid epithelial cells linked to failed regeneration, expansion of (iii) profibrotic SPP1+ macrophages and (iv) disease-associated CTHRC1+ and HAS1hi fibroblast subtypes, that localise to fibrotic niches, and (v) extensive vascular and immune remodelling. In COPD these approaches demonstrate: (i) loss of aerocytes; (ii) expansion of MMP-expressing macrophages, (iii) activated neutrophil influx and (iv) B-cell lymphoid follicle activation and endothelial inflammation (iv) some overlapping features with IPF. We highlight gaps and future opportunities, including under-representation of early disease stages, incomplete resolution of neutrophils, tissue-resident immune compartments, and cross-organ integration. Looking forward, integration with clinical phenotypes and imaging is accelerating translation towards precision medicine, enabling biomarker discovery, cellular endotyping, and therapeutic prioritisation. Advances in multimodal profiling, computational pipelines, next generation technologies, open science initiatives and artificial intelligence will propel the field toward predictive, patient-specific insight and mechanistically informed, stratified trial design.
引用
- Mehta P, He C, Mawar CMA, et al. Single-cell multi-omics in IPF and COPD: from atlas to impact. Eur Respir J. 2026. PMID: 42880940. doi:10.1183/13993003.00023-2026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。